Clinical Trial Update: Atorvastatin Study in Cardiovascular Disease Risk

View source ↗

Summary

A completed clinical trial evaluating atorvastatin for cardiovascular disease risk in patients with hypercholesterolemia or dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Hypercholesterolemia, Dyslipidemia | Status: COMPLETED